Extendicare (TSE:EXE) Stock Rating Upgraded by Cormark

Extendicare (TSE:EXEGet Free Report) was upgraded by Cormark to a “moderate buy” rating in a research note issued to investors on Wednesday,Zacks.com reports.

Other analysts have also recently issued reports about the company. TD Securities raised their price objective on Extendicare from C$9.50 to C$10.50 and gave the company a “hold” rating in a research report on Thursday, November 14th. BMO Capital Markets set a C$11.00 price target on Extendicare and gave the company a “market perform” rating in a research note on Thursday, January 30th. Finally, Royal Bank of Canada lifted their price objective on shares of Extendicare from C$9.50 to C$11.00 and gave the stock a “sector perform” rating in a research report on Thursday, November 28th. Three equities research analysts have rated the stock with a hold rating and one has given a buy rating to the company. According to data from MarketBeat.com, the company has a consensus rating of “Hold” and a consensus price target of C$10.25.

Check Out Our Latest Analysis on EXE

Extendicare Stock Up 2.1 %

Shares of EXE stock opened at C$11.58 on Wednesday. Extendicare has a 52-week low of C$6.63 and a 52-week high of C$11.62. The stock has a market cap of C$966.55 million, a price-to-earnings ratio of 14.76 and a beta of 1.26. The firm’s 50-day moving average is C$10.47 and its 200-day moving average is C$9.56. The company has a debt-to-equity ratio of 283.02, a quick ratio of 0.98 and a current ratio of 0.62.

About Extendicare

(Get Free Report)

Extendicare Inc, operating solely in Canada, is the largest private-sector owner and operator of long-term care (LTC”) homes and one of the largest private-sector providers of publicly funded home health care services.

Featured Stories

Receive News & Ratings for Extendicare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Extendicare and related companies with MarketBeat.com's FREE daily email newsletter.